A/s Novo, 10% Owner at Tobira Therapeutics, Inc. (TBRA), sold 59,067 shares at $12.19 ($710K) on 2016-07-11, disclosed to the SEC on 2016-07-13.
Open-market sale of $710k TBRA by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $12.19 | 20,431 | $249K | 35.1% |
| 2 | $12.12 | 8,752 | $106K | 14.9% |
| 3 | $11.88 | 29,884 | $355K | 50.0% |
| Total | $12.02 avg | 59,067 | $710K | 100% |
| Filing → |
| RETA | SELL | 2017-06-07 | $2.5M | — | Filing → |
| APEN | SELL | 2017-05-11 | $582K | — | Filing → |
| OPHT | SELL | 2016-12-16 | $17.6M | — | Filing → |